Stock PHAR PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Pharming Group N.V. Nasdaq

Equities

PHAR

US71716E1055

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-24 EDT 		5-day change 1st Jan Change
8.27 USD +13.76% Intraday chart for Pharming Group N.V. +0.55% -27.65%
05-31 Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug MT
05-30 Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pharming Group N.V. Appoints Richard Peters as Non-Executive Director
CI
Pharming Group N.V. Appoints Alexander Breidenbach as Chief Business Officer
CI
Pharming Group Nominates Richard Peters as Chairman
MT
Pharming Group N.V. Approves the Proposal to Reappoint Paul Sekhri, Chair of the Board, as Non-Executive Director for A Period of One Year Who Will Resign from the Board Upon Appointment of His Successor
CI
Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer and Executive Board Member
CI
Pharming Group N.V. Announces Executive Changes
CI
Pharming Group N.V. Announces Executive Changes
CI
Pharming Group N.V. Announces Board Changes
CI
Pharming Group N.V. Announces Board Appointments
CI
Pharming Group N.V. Announces Management Changes
CI
Pharming Group N.V. Appoints Jeroen Wakkerman as Chief Financial Officer, Effective 16 November 2020
CI
Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors
CI
Pharming Group N.V. Announces Not to Put for Re-Election of Robin Wright as Member of the Board of Management and Chief Financial Officer
CI
Pharming Group N.V. Announces Retirement of Jaap Blaak as Chairman of the Board of Supervisory Directors
CI
Pharming Group NV Announces Management Changes
CI
Pharming Group NV Appoints Mr. Robin Wright as Member of Board and CFO
CI
Pharming Group NV Nominates Robin Wright as Chief Financial Officer and Member of the Management Board
CI
Pharming Group NV Announces the Nominations of Paul Jai Sekhri and Jan Hendrik Egberts as Members of its Board of Supervisory Directors
CI
Pharming Group NV Appoints Perry Calias as Chief Scientific Officer
CI
Pharming Group N.V. Announces Resignation of Rienk Pijpstra from the Board of Management, Effective on September 1, 2012
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. PHAR Stock
  5. News Pharming Group N.V.
  6. Insiders